India to miss end-July vaccination target as Bharat Biotech lags
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard

Sunday
July 03, 2022

Sign In
Subscribe
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
SUNDAY, JULY 03, 2022
India to miss end-July vaccination target as Bharat Biotech lags

Coronavirus chronicle

Reuters
26 July, 2021, 08:25 pm
Last modified: 26 July, 2021, 08:29 pm

Related News

  • India sees 45% jump in a day with 17,073 new Covid cases
  • India gives nod to Bharat Biotech for intranasal Covid booster doses
  • India vaccinates 3.8 million teens in new Covid-19 inoculation push
  • India's Modi calls meeting of state chiefs on fighting Omicron variant
  • WHO issues emergency use listing for COVAXIN Covid-19 jab

India to miss end-July vaccination target as Bharat Biotech lags

India has undertaken one of the world's largest vaccination drives and has so far distributed some 430 million doses - more than any country except China, but less than many countries relative to its population

Reuters
26 July, 2021, 08:25 pm
Last modified: 26 July, 2021, 08:29 pm
The Covid-19 active cases in the country have further declined to 4,59,920 and constitute 1.52 per cent of the caseload. Photo :AFP via Hindustan Times
The Covid-19 active cases in the country have further declined to 4,59,920 and constitute 1.52 per cent of the caseload. Photo :AFP via Hindustan Times

India will miss a target to administer over a half billion Covid-19 vaccine doses by the end of the month as Bharat Biotech - maker of its only approved homegrown shot - struggles to boost output, an analysis of government data showed on Monday.

India has undertaken one of the world's largest vaccination drives and has so far distributed some 430 million doses - more than any country except China, but less than many countries relative to its population.

The government said in May it would make 516 million shots available by the end of July. It wants to inoculate all its estimated 944 million adults by December.

To meet the July-end target, however, authorities will have to more than triple average daily vaccinations to 14 million doses. But that will not be possible, based on the latest supply projections for Bharat Biotech's Covaxin vaccine.

The government had been counting on deliveries of 60 million to 70 million Covaxin doses monthly from July or August.

But Bharat Biotech will only supply 25 million doses this month and 35 million in August as a new production line in the southern city of Bengaluru takes time to come online, Health Minister Mansukh Mandaviya told parliament last week.

Mandaviya added that the supply shortfall "would not affect our immunisation programme".

The health ministry did no immediately respond to a request for comment. Bharat Biotech declined to comment on its production.

The government is counting on 500 million doses of another vaccine from the Serum Institute of India (SII) and 400 million doses from Bharat Biotech between August and December for its vaccination campaign.

India's drug regulator controversially approved Bharat Biotech's Covaxin for emergency use in early January without efficacy data. But it has missed nearly all supply commitments to the government. 

Immunisation efforts have also been hobbled by a delayed rollout of Russia's Sputnik V vaccine. And legal obstacles have prevented India from receiving US donations of Moderna or Pfizer vaccines.

After halting exports in mid-April to meet domestic demand, SII meanwhile has nearly doubled output in the past three months.

Nearly 88% of all vaccine doses administered in India to date have been SII's Covishield shot, a version of the AstraZeneca vaccine.

The government expects the company to raise supplies of its Covishield vaccine to about 120 million doses in August from 100 million doses in June.

Top News / World+Biz / South Asia

India Covid Crisis / Bharat Biotech Covid-19 vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Something's rotten in small-cap scrip rally: Experts
    Something's rotten in small-cap scrip rally: Experts
  • Representational Image. Photo: Courtesy
    Mobile internet users hit hard by VAT hike
  • Photo: Mumit M
    Launch routes suffer over 50% passenger drop

MOST VIEWED

  • Former North Korean defectors living in South Korea, release balloons containing one dollar banknotes, radios, CDs and leaflets denouncing the North Korean regime, towards the north near the demilitarized zone which separates the two Koreas in Paju, north of Seoul January 15, 2014. REUTERS/Kim Hong-Ji/File Photo
    North Korea blames 'alien things' near border with South for Covid outbreak
  • People wearing protective face masks commute amid concerns over the new coronavirus disease (COVID-19) in Pyongyang, North Korea March 30, 2020, in this photo released by Kyodo. Picture taken March 30, 2020. Mandatory credit Kyodo/via REUTERS
    S Korea says leaflets sent by defectors unlikely to be cause of Covid in N Korea
  • Test tubes are seen in front of displayed Pfizer and Biontech logos in this illustration taken, May 21, 2021. Reuters: llustration
    BioNTech, Pfizer to start testing universal vaccine for coronaviruses
  • A woman holds a small bottle labelled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in this illustration taken October 30, 2020. REUTERS/Dado Ruvic/File Photo
    S Korea approves first domestically developed Covid vaccine
  • Photo: Collected
    US medical experts call for Omicron-specific Covid boosters
  • David E Adler. Sketch: TBS
    Who managed Covid-19 best, and why?

Related News

  • India sees 45% jump in a day with 17,073 new Covid cases
  • India gives nod to Bharat Biotech for intranasal Covid booster doses
  • India vaccinates 3.8 million teens in new Covid-19 inoculation push
  • India's Modi calls meeting of state chiefs on fighting Omicron variant
  • WHO issues emergency use listing for COVAXIN Covid-19 jab

Features

The eye-catching commuter: Suzuki Gixxer SF 155

The eye-catching commuter: Suzuki Gixxer SF 155

20h | Wheels
Photo: Collected

Sapiens – A Graphic History 

1d | Book Review
Black-naped Monarch male  Photo: Enam Ul Haque

Black-naped Monarch: A sovereign who never abandoned the Indian subcontinent

1d | Panorama
The 136-year-old company on its last legs

The 136-year-old company on its last legs

1d | Features

More Videos from TBS

Bangabandhu Tunnel to change lives of million

Bangabandhu Tunnel to change lives of million

7h | Videos
Sowari Ghat's fresh fish market

Sowari Ghat's fresh fish market

7h | Videos
Ukraine changes war strategy under Russian pressure

Ukraine changes war strategy under Russian pressure

8h | Videos
Rajshahi Metropolitan Police observes 30th founding anniversary

Rajshahi Metropolitan Police observes 30th founding anniversary

10h | Videos

Most Read

1
Padma Bridge from satellite. Photo: Screengrab
Bangladesh

Padma Bridge from satellite 

2
Meet the man behind 'Azke amar mon balo nei'
Splash

Meet the man behind 'Azke amar mon balo nei'

3
TBS Illustration
Education

Universities may launch online classes again after Eid

4
Photo: TBS
Bangladesh

Motorcycles banned on Padma Bridge 

5
Photo: Collected
Economy

Tech startup ShopUp bags $65m in Series B4 funding

6
World Bank to give Bangladesh $18b IDA loans in next five years
Economy

World Bank to give Bangladesh $18b IDA loans in next five years

EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2022
The Business Standard All rights reserved
Technical Partner: RSI Lab
BENEATH THE SURFACE
The Dazzling Fake Flowers: Is there any alternative to artificial flowers while decorating homes, showrooms, offices and business establishments? Fresh flowers are undoubtedly beautiful, but they dry out quickly. Hence, the demand for plastic flowers is rising day by day. Traders said these lifelike silk flowers usually come from China and Thailand. The photo was taken from the 29th International Trade Fair of the Chattogram Chamber on Friday. PHOTO: Mohammad Minhaj Uddin

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net